Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dual trigger versus hCG trigger in GnRH antagonist IVF/ICSI cycles for women with PCOS
ChiCTR2200056317Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Chongqing Medical University
- Start
- Mar 2022
- Modality
- Recombinant Proteins and Enzymes, Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, open-label trial of human chorionic gonadotropin and triptorelin in polycystic ovary syndrome (PCOS) (2 arms), sponsored by First Affiliated Hospital of Chongqing Medical University. Primary endpoints: Number of oocytes retrieved, Available embryo number and 1 more. Planned start Mar 2022; status: not yet recruiting.
02
Drugs
human chorionic gonadotropintriptorelin
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on ChiCTR2200056317.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200056317.